The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn More
We all push the boundaries and cut corners, whether it’s using our cellphone while driving, jaywalking, wearing a mask under our nose or chin, or some other transgression. These minor behavioral violations never make the headlines. Yet even these small infractions can, cumulatively, cause extensive damage to society — with life or death consequences. For example, if no one wears their mask properly, COVID-19 could spread unabated, endangering countless lives. How can society crack down on these behaviors? More frequent enforcement requires more resources like security cameras. More severe punishment for such infractions may lead to public opposition. There’s no…
Are you a morning lark or a night owl? Whether you’re a “morning person” or a “night person” may have something to do with your gut bacteria. A collaborative research project between the University of Haifa and the Technion has found that “morning people” and “night people” differ from each other in their gut microbiome – the bacterial populations that inhabit our digestive tract. The study was conducted in collaboration between researchers and a number of research groups at the two universities: Assistant Professor Naama Geva-Zatorsky, head of the Microbiome Research Lab of the Rappaport Faculty of Medicine at the…
“Sutures? That’s practically medieval!” It is a staple of science fiction to mock sutures as outdated. After all, the technique has been in use for at least 5,000 years. Professor Hossam Haick from the Wolfson Department of Chemical Engineering at the Technion has finally turned science fiction into reality. His lab created a smart, sutureless dressing that binds the wound together, wards off infection, and reports on the wound’s condition directly to the doctors’ computers. “I was watching a movie on futuristic robotics with my kids late one night,” said Prof. Haick, “and I thought, what if we could really…
The technology, based on the Nano-Ghosts platform, makes it possible to reduce the drug dose a million-fold without reducing its efficacy. Researchers in the Faculty of Biotechnology and Food Engineering at the Technion developed a technology that inhibits development of melanoma using one-millionth of the active ingredient. The study, published in Advanced Functional Materials, was led by Professor Marcelle Machluf, dean of the faculty, and Ph.D. student Lior Levy. This development is a significant breakthrough in the field of immunotherapy — an innovative medical approach that uses the body’s own immune system to destroy cancer cells. Immunotherapy can destroy cancer…
The National Academy of Inventors and the Intellectual Property Owners Association (collectively known as NAI-IPO) has ranked the Technion – Israel Institute of Technology as one of the top 100 worldwide universities granted U.S. utility patents. The achievement is yet another international recognition of the Technion’s rigorously entrepreneurial and innovative spirit on campus — an ethos that has produced thousands of inventions from both researchers and alumni, including a device that uses AI to detect the scent of more than 23 specific disease biomarkers in a person’s breath, the USB flash drive, and a robotic suit that enables paraplegics to…
Researchers at the Technion – Israel Institute of Technology, in collaboration with researchers from Le Centre National de la Recherche Scientifique (CNRS) in Toulouse, France, discovered an artificial molecule that may inhibit the development of Alzheimer’s disease. The molecule breaks down the toxic chemical complex Cu–Aβ, inhibiting the cell death that is thought to be related to Alzheimer’s. The study was led by Professor Galia Maayan and doctoral student Anastasia Behar from the Schulich Faculty of Chemistry, in collaboration with Professor Christelle Hureau from the Laboratoire de Chimie de Coordination du CNRS.
A new algorithm developed by the Technion – Israel Institute of Technology helps doctors select more effective, personalized antibiotic treatments for patients. After doctors at Maccabi Healthcare Services adopted the algorithm for patients with urinary tract infections (UTIs), they saw a 35% drop in the need to switch a patient’s antibiotic regimen. Maccabi first applied the algorithm to patients with urinary tract infections (UTIs) – the most common bacterial infection among women. Around 30% of women suffer from UTIs at least once during their lifetimes, and up to 10% experience recurrent infections. Until now, in most cases general treatment has…
Every day, manufacturing companies face costly equipment failures. What if they could detect that leaky valve before it leaked? Alumni-founded Feelit Technologies Ltd. predicts and solves machinery problems before they happen — preventing potentially dangerous equipment failures and reducing the cost of manual inspections and production downtime associated with finding and fixing faults. Feelit technology is based on sensor-packed stickers printed with nanoparticle ink. When affixed to pipes, pumps, or valves, the sensors monitor pressure, temperature, vibration, leakage, wall integrity, thickness, and other industrial parameters. The data is then analyzed in the cloud in real time and sent back to…
Pictured Above / Prof. Mirela Ben-Chen To anyone who’s seen videos of robotic arms in motion, lifting and interlocking parts in construction, it’s clear that computer science has everyday applications. In fact, the use of increasingly sophisticated robots in architectural design and manufacturing is seen as a major technological trend in the construction industry. But while complex architectural projects are often planned on computers, they are executed using construction methods that have remained virtually unchanged for decades. Human intervention is usually necessary, especially when architectural planning is based on complex spatial systems such as thin, doubly curved surfaces, known as…
Technion – Israel Institute of Technology Assistant Professor Assaf Zinger and Dr. Caroline Cvetkovic from the Center for Neuroregeneration at the Houston Methodist Research Institute have created a novel means of delivering medicine to neurons in a targeted manner. The biomimetic nano-vesicles, or nature-mimicking, nanometer-scale “vehicles,” are capable of specifically targeting neurons such as nerve cells. These nano-vehicles pave the way for the treatment of multiple neurodegenerative diseases and traumatic brain injuries.
Pictured above: Professor Shulamit Levenberg (Left) and Ph.D. student Rita Beckerman The Technion has developed a novel approach to treat type 2 diabetes. Led by Professor Shulamit Levenberg and Ph.D. student Rita Beckerman, the treatment uses an autograft of muscle cells engineered to take in sugar at increased rates. Mice treated in this manner displayed normal blood sugar levels for months after a single procedure. Prof. Levenberg is the director of the Rina & Avner Schneur Center for Diabetes Research and the Technion Center for 3D Bioprinting, and holds the Stanley and Sylvia Shirvan Chair in Cancer and Life Sciences…